Merck KGaA (OTCMKTS:MKGAF) Shares Down 5.3% – Here’s Why

Merck KGaA (OTCMKTS:MKGAFGet Free Report) fell 5.3% during mid-day trading on Monday . The stock traded as low as $155.0850 and last traded at $155.0850. 178 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 650 shares. The stock had previously closed at $163.7780.

Merck KGaA Stock Down 5.3%

The stock has a market cap of $20.04 billion, a PE ratio of 23.68 and a beta of 0.96. The firm has a fifty day moving average of $138.62 and a 200 day moving average of $141.68. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Read More

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.